Mumbai, India , is rapidly emerging as a vital hub for the production of Lenacapavir Sodium API (CAS 2189684-53-3). Several organizations have established substantial manufacturing facilities focusing on this critical antiviral medicine . Identifying the definitive top manufacturers can be difficult due to fluctuating market dynamics, but reputable